Pharmaceuticals
Atonarp Announces $50M Series D Financing to Scale its Molecular Sensing and Digital Diagnostics Testing Platforms
Michael Marks, Founding Partner for WRVI Capital, Joins the Atonarp Board and Former Berkeley Lights CFO Shaun Holt Joins as Atonarp's Chief Operating Officer TOKYO, May 18, 2021 /PRNewswire/ -- Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, phar...
2021-05-18 18:00
2787
Nanoform's final clinical results confirm value proposition to the pharma industry
HELSINKI, Finland, May 18, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform "), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical study. The primary, secondary and optional exploratory objectives of the study were all met. Th...
2021-05-18 13:48
1254
U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer
SAN FRANCISCO and SUZHOU, China, May 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX: 01801) and Eli Lilly and Company (NYSE: LLY) today jointly announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for sintilimab injection in...
2021-05-18 12:14
12334
Clover Announces Positive Preclinical Data for Second-Generation Protein-Based COVID-19 Vaccine Candidate Demonstrating Broad Neutralization Against Variants of Concern
* The publication is available as a pre-print on bioRxiv * Preclinical data demonstrates that a modified B.1.351 S-Trimer vaccine candidate induces broad neutralization against both the original SARS-CoV-2 strain and variants of concern (VoC) including the South African variant * A single bo...
2021-05-18 11:50
2604
Farrer Park Hospital Elevates Cancer Care with PIPAC Treatment for Late to End-stage Cancer Patients
SINGAPORE, May 18, 2021 /PRNewswire/ -- Farrer Park Hospital
2021-05-18 08:15
1919
EpiVax Identifies T cell Epitopes critical to robust T cell immune response in SARS-CoV-2 , Results Published in NPJ Vaccines
PROVIDENCE, R.I., May 17, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces the publication"Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation" in NPJ Vaccines. This research identifies peptide epitopes associated with T...
2021-05-17 20:54
1879
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
Dr. Dansey, Seagen's Chief Medical Officer, brings extensive expertise in immuno-oncology and drug development Appointment of industry leader in drug development expands the Board's diverse industry, clinical development, research and commercialization expertise PLYMOUTH MEETING, Pa., May 17, 20...
2021-05-17 20:00
3761
Everest Medicines Announces China NMPA Has Accepted Biologics License Application for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer
SHANGHAI, May 17, 2021 /PRNewswire/ -- Everest Medicines
2021-05-17 16:51
3378
Nippon Express (China) Becomes First Japanese Company to Acquire GDP Certification in China
TOKYO, May 17, 2021 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NE China"), a local subsidiary of Nippon Express Co., Ltd., has obtained Good Distribution Practice (GDP) certification, effectiveMonday, March 29, 2021, for its Shanghai Pudong Airport CFS, making it the first Jap...
2021-05-17 15:00
2413
Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
SAN FRANCISCO and SUZHOU, China, May 17, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2021-05-17 09:00
4156
Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial
SHANGHAI and HONG KONG, May 17, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and onc...
2021-05-17 08:00
2757
Luye Life Sciences Unveils Cutting-edge Advances in Gene and Cell Therapy at ASGCT 2021
BOSTON, May 13, 2021 /PRNewswire/ -- The Boston R&D Center and GeneLeap Biotech, two subsidiaries of Luye Life Sciences Group, took part in the 24th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, presenting the progress of four of the company's latest preclinical developments in ...
2021-05-14 11:58
2316
Final Results of Bioavailability Study of Phebra's Oral Arsenic Capsule for Acute Promyelocytic Leukaemia (APL) Confirm Bioequivalence of Oral and IV Formulations
SYDNEY, May 13, 2021 /PRNewswire/ -- Australian pharmaceutical group Phebra (' Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP433 at the virtual European Hematology Association (EHA) 2021 Conference. The abstract builds on the initi...
2021-05-14 10:33
1150
Antengene Announces the IND Approval for Eltanexor in Patients with Advanced Solid Tumors in Mainland China
SHANGHAI and HONG KONG, May 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-05-14 08:40
3364
I-Mab Added to MSCI China Index
SHANGHAI and GAITHERSBURG, Md., May 13, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab has been selected for inclusion in the MSCI Ch...
2021-05-13 20:00
5116
An oral antiviral drug from Korea may be a problem solver for COVID-19
SEOUL, South Korea, May 13, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced that Dr.Jin-Ho Choi, a Chief Scientist of its major shareholding bio tech company CNPharm and Chair Professor at Dankook University, presented the study titled 'COVID-19 Game Changer Drug – a novel orga...
2021-05-13 16:37
1763
Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities
BAGSVÆRD, Denmark, May 13, 2021 /PRNewswire/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-we...
2021-05-13 13:00
1549
Ascentage Pharma (6855.HK) Becomes a Constituent of MSCI China Small Cap Index
SUZHOU, China and ROCKVILLE, Md., May 13, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that according to the latest ...
2021-05-13 08:28
2041
Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 in patients with mild COVID-19
Product recently cleared in EU as Class III medical device BALERNA, Switzerland, May 13, 2021 /PRNewswire/ -- APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the ...
2021-05-13 00:48
2450
Discover Six Dynamic Trends to Disrupt the Next Generation of Biopharmaceutical Manufacturing
Technology, industry collaborations and a desire to innovate will help participants sustain their growth momentum and achieve manufacturing scale, finds Frost & Sullivan SANTA CLARA, Calif., May 12, 2021 /PRNewswire/ -- The biopharmaceutical industry is facing its biggest test in recent times. A...
2021-05-12 18:12
1496
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8873
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7709